APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 59 filers reported holding APTEVO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | 0.0% | 11,296 | -4.9% | 0.00% | – |
| Q3 2019 | $7,000 | -30.0% | 11,880 | +4.4% | 0.00% | – |
| Q2 2019 | $10,000 | +900.0% | 11,380 | +724.6% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 1,380 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -88.2% | 1,380 | -59.7% | 0.00% | – |
| Q3 2018 | $17,000 | 0.0% | 3,425 | +1.3% | 0.00% | – |
| Q2 2018 | $17,000 | +240.0% | 3,380 | +144.9% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 1,380 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | +100.0% | 1,380 | -1.2% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 1,397 | +1.2% | 0.00% | – |
| Q2 2017 | $3,000 | -40.0% | 1,380 | -37.0% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 2,191 | -28.3% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 3,057 | +105.3% | 0.00% | – |
| Q3 2016 | $4,000 | – | 1,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,920,368 | $4,686,000 | 0.88% |
| Fondren Management LP | 388,355 | $948,000 | 0.68% |
| Perceptive Advisors | 988,133 | $2,411,000 | 0.17% |
| CSS LLC/IL | 353,977 | $864,000 | 0.05% |
| GLG Partners LP | 357,834 | $873,000 | 0.04% |
| Acrospire Investment Management LLC | 23,144 | $56,000 | 0.02% |
| Laurel Wealth Advisors, Inc. | 16,850 | $41,000 | 0.02% |
| Capital Impact Advisors, LLC | 12,318 | $30,000 | 0.01% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 43,559 | $106,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $24,000 | 0.01% |